Heron Therapeutics CFO reports RSU vesting and taxes

Heron Therapeutics EVP and Chief Financial Officer Ira Duarte reported equity compensation activity involving restricted stock units (RSUs).

Rhea-AI Filing Summary

Heron Therapeutics EVP and Chief Financial Officer Ira Duarte reported equity compensation activity involving restricted stock units (RSUs). On July 19, 2026, 3,874 RSUs converted into common stock, and 1,101 shares were withheld at $0.47 per share for taxes. After these transactions, filings show 263,846 common shares held directly and 23,246 restricted stock units remaining, as part of an award that vests in 16 equal quarterly installments beginning one quarter after the January 19, 2024 grant date.

Insider Trade Summary

3,874 shares exercised/converted

Exercise 3 txns

Insider Duarte Ira

Role EVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F2	3,874	$0.00	$0.00
Exercise	Common Stock F1	3,874	--	--
Exercise Price or Tax Liability	Common Stock	1,101	$0.47	$517.47

Holdings After Transaction: Restricted Stock Units — 23,246 contracts (Direct); Common Stock — 263,846 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
2. F2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Key Figures

RSUs Converted to Common Stock: 3,874 shares Shares Withheld for Taxes: 1,101 shares Tax Withholding Price: $0.47 per share +3 more

6 metrics

RSUs Converted to Common Stock 3,874 shares Restricted stock units converted into common stock on July 19, 2026

Shares Withheld for Taxes 1,101 shares Common shares withheld at $0.47 per share to satisfy tax obligations

Tax Withholding Price $0.47 per share Value applied to the 1,101 shares used for tax withholding

Direct Common Shares After Transactions 263,846 shares Directly held Heron Therapeutics common stock after tax-withholding disposition

RSUs Remaining After Conversion 23,246 units Restricted stock units remaining outstanding following the 3,874-unit conversion

RSU Vesting Installments 16 quarterly installments Award vests in 16 equal quarterly installments after the January 19, 2024 grant

Key Terms

Restricted Stock Units, tax-withholding disposition, derivative security

3 terms

Restricted Stock Units financial

"Security title reported as "Restricted Stock Units" with 3,874 units converted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"Transaction action described as a "tax-withholding disposition" of 1,101 shares"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative security financial

"Transaction code description notes an "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HRTX executive Ira Duarte report on July 19, 2026?

Ira Duarte reported 3,874 restricted stock units converting into common stock and 1,101 shares withheld at $0.47 per share to cover taxes. These movements reflect equity compensation mechanics rather than open-market purchases or sales of Heron Therapeutics stock.

How many Heron Therapeutics (HRTX) shares and RSUs does Ira Duarte hold after these transactions?

Following the reported transactions, filings list 263,846 common shares held directly by Ira Duarte and 23,246 restricted stock units remaining. The RSUs are part of an award scheduled to vest in equal quarterly installments after the January 19, 2024 grant date.

At what price were HRTX shares withheld to cover Ira Duarte’s tax obligations?

The filing shows 1,101 common shares withheld for taxes at $0.47 per share. This tax-withholding disposition satisfies a tax liability using shares rather than cash and does not represent an open-market sale initiated by the executive.

What is the vesting schedule for Ira Duarte’s HRTX restricted stock units?

According to the footnotes, the restricted stock units vest in 16 equal quarterly installments, beginning one quarter after the January 19, 2024 grant date. After the July 19, 2026 conversion of 3,874 RSUs, 23,246 units from this award remain outstanding.

Were Ira Duarte’s July 2026 HRTX transactions made under a Rule 10b5-1 trading plan?

The Form 4 does not indicate use of a Rule 10b5-1 trading plan. The document-level 10b5-1 checkbox is not marked affirmatively, and no footnote describes the transactions as occurring pursuant to a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 03:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duarte Ira

(Last) (First) (Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY NORTH CAROLINA 27511

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/19/2026		M		3,874	A	(1)	264,947	D
Common Stock	07/19/2026		F		1,101	D	$0.47	263,846	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	07/19/2026		M			3,874	(2)	(2)	Common Stock	3,874	$0	23,246	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

	/s/Kathryn Lester Attorney-in-fact for Ira Duarte	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)